Drug reference
vibegron
β3-selective adrenergic receptor agonist · Urinary Antispasmodic
β3-selective adrenergic receptor agonistUrinary AntispasmodicATC G04BD14
CDSCO approvedATC G04BD14
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Vibegron is a β3-selective adrenergic receptor agonist that relaxes bladder detrusor muscle.
Indications
overactive bladder syndrome
Drug interactions
9 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Related guidelines
Empirical antimicrobial use in common syndromes
ICMR · Infectious Diseases · 2019
Acute coronary syndrome in chronic kidney disease
CSI · Cardiology · 2020
Sjögren's syndrome
EULAR · Rheumatology · 2025
Primary PCI for acute coronary syndrome
ESC · Cardiology · 2026
Preoperative cardiac evaluation for non-cardiac surgery
AHA · Cardiology · 2025
Ask House about vibegron
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10